New injection combo targets Hard-to-Treat tumors
Disease control
Recruiting now
This study tests a new treatment for people with advanced solid tumors that have not responded to standard therapies. The treatment involves two injections given directly into the tumor, one after the other, every two weeks. The goal is to find a safe dose and see if it can shrin…
Phase: PHASE1, PHASE2 • Sponsor: Binhui Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC